Biliary tract tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with biliary malignant tumors that can undergo radical resection; (2) Refer to the UICC/AJCC TNM staging system (8th edition in 2017); (3) Agree to provide archived tumor tissue specimens or fresh tissue samples (which must have tissue specimens) and blood samples collected at different time nodes; (4) ECOG PS score 0-1; (5) The expected survival period is greater than 3 months; (6) Age 18-80 years old; (7) Willing to sign an informed consent form; (8) Patients can be followed up on schedule, can communicate well with the investigator and can complete the study in accordance with the research regulations.
Exclusion criteria
Exclusion criteria: (1) A patient with a previous malignancy shall not participate in the study unless he/she has complete remission for at least 5 years prior to enrolment and does not need to receive additional treatment or does not need to be admitted during the study Subject to other treatments (2) Combined severe medical diseases include, but are not limited to, uncontrolled diabetic active peptic ulcer active bleeding, etc (3) The method of sample collection and preservation is not standardized; (4) The relevant information of the subject is incomplete; (5) Patients who do not have enough communication, understanding and cooperation, or poor compliance, and cannot guarantee the completion of follow-up as required; (6) The investigator believes that the subject who is not suitable for participating in this clinical trial for various other reasons withdraws from the study or terminates the study treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| routine blood test;urinalysis; | — |
Countries
China
Contacts
Hohhot First Hospital